Literature DB >> 3140597

A simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN gamma.

H Gallati1, I Pracht, J Schmidt, P Häring, G Garotta.   

Abstract

A rapid and sensitive enzyme-immunoassay for native and recombinant human interferon gamma is described. The test is performed in one step at room temperature and is based on the sandwich principle. The IFN gamma preparation is distributed with horse radish peroxidase-labeled monoclonal antibody to IFN gamma in microtiter plates previously coated with a second mab against IFN gamma. The amount of the IFN gamma mab sandwich fixed in the microtiter plate wells is proportional to the color developed after the addition of peroxidase-specific substrate. The two mab's used in the test neutralize IFN gamma and are directed against the same epitope. For this reason they can only detect the biologically active dimeric form of IFN gamma. The IFN gamma-ELISA works in phosphate buffer as well as in tissue culture medium or human serum. As the assay is routinely performed in 2 hours, the limit of detection is 3 U/ml of IFN gamma (0.3 ng/ml). If the assay is performed in 16 hours, the limit of detection decreases to 0.5 U/ml IFN gamma (0.06 ng/ml). The conditions to preserve the activity of IFN gamma preparation as standard are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3140597

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  21 in total

1.  Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells.

Authors:  C Jochum; R Voth; S Rossol; K H Meyer zum Büschenfelde; G Hess; H Will; H C Schröder; R Steffen; W E Müller
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.

Authors:  M J Hussain; M Peakman; H Gallati; S S Lo; M Hawa; G C Viberti; P J Watkins; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

3.  Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

Authors:  P Panina-Bordignon; D Mazzeo; P D Lucia; D D'Ambrosio; R Lang; L Fabbri; C Self; F Sinigaglia
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Activation of human T lymphocytes: differential effects of CD3- and CD8-mediated signals.

Authors:  Y Samstag; F Emmrich; T Staehelin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Impaired cytokine production in whole blood cell cultures of patients with urological carcinomas.

Authors:  U Elsässer-Beile; S von Kleist; R Fischer; M Martin; U Wetterauer; H Gallati; J S Mönting
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  CD1a and MHC class I follow a similar endocytic recycling pathway.

Authors:  Duarte C Barral; Marco Cavallari; Peter J McCormick; Salil Garg; Anthony I Magee; Juan S Bonifacino; Gennaro De Libero; Michael B Brenner
Journal:  Traffic       Date:  2008-06-28       Impact factor: 6.215

7.  Cytokine production in whole blood cell cultures of patients undergoing therapy with biological response modifiers or 5-fluorouracil.

Authors:  U Elsässer-Beile; S von Kleist; A Lindenthal; R Birken; H Gallati; J S Mönting
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

8.  Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV) infection.

Authors:  G Hess; S Rossol; R Rossol; K H Meyer zum Büschenfelde
Journal:  Infection       Date:  1991       Impact factor: 3.553

9.  Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subset.

Authors:  J F Schlaak; P Nieder; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

10.  Cytokine-mediated regulation of monocyte/macrophage cytotoxicity in human immunodeficiency virus-1 infection.

Authors:  S Rossol; G Gianni; R Rossol-Voth; H Gallati; W E Müller; K H Meyer zum Büschenfelde
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.